Home › Funds › GENERAL AMERICAN INVESTORS CO INC › IDYA

GENERAL AMERICAN INVESTORS CO INC position in IDYA

IDEAYA BIOSCIENCES INC · Health Care

GENERAL AMERICAN INVESTORS CO INC reported holding 308,240 shares of IDYA (IDEAYA BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$11.8M, representing 0.75% of its reported portfolio and ranking #44 among its reported holdings. GENERAL AMERICAN INVESTORS CO INC has disclosed IDYA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)308.24K sh
Reported value held$11.84M
Portfolio Weight0.75%
First reportedQ3 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GENERAL AMERICAN INVESTORS CO INC's IDYA position evolved

GENERAL AMERICAN INVESTORS CO INC first disclosed a stake in IDYA in Q3 2024 at 90,000 shares (US$2.9M). The position peaked in Q3 2026 at 308,240 shares, worth US$11.8M. Across 9 filings, GENERAL AMERICAN INVESTORS CO INC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 308,240 shares valued at US$11.8M. Notable position changes include a 34% increase in Q4 2024 (shares fell 36% over the following quarter), a 116% increase in Q1 2025 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 90.00K $2.85M New
Q4 2024 120.26K $3.09M Add
Q1 2025 260.26K $4.26M Add
Q2 2025 260.26K $5.47M Hold
Q3 2025 280.26K $7.63M Add
Q4 2025 280.26K $9.69M Hold
Q1 2026 280.26K $9.34M Hold
Q2 2026 308.24K $11.49M Add
Q3 2026 308.24K $11.84M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IDYA and 13F data

IDYA (IDEAYA BIOSCIENCES INC) is a Health Care company. 36 other funds we track also report a position in IDYA — the largest reported positions include BAKER BROS. ADVISORS LP (US$186.7M), Logos Global Management LP (US$111.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$101.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IDYA

All IDYA fund holders →

FAQ

How long has GENERAL AMERICAN INVESTORS CO INC held IDYA?

GENERAL AMERICAN INVESTORS CO INC has disclosed IDYA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is GENERAL AMERICAN INVESTORS CO INC's current position in IDYA?

As of Q3 2026, GENERAL AMERICAN INVESTORS CO INC holds 308.24K shares of IDYA (IDEAYA BIOSCIENCES INC), valued at $11.84M, representing 0.75% of its reported portfolio and ranking #44.

Has GENERAL AMERICAN INVESTORS CO INC been buying or selling IDYA?

In the latest 13F filing (Q3 2026), GENERAL AMERICAN INVESTORS CO INC held unchanged its position in IDYA. The position peaked in Q3 2026 at 308.24K shares.

Which other funds hold IDYA?

Other major institutional holders of IDYA include BAKER BROS. ADVISORS LP, Logos Global Management LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.